Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Interest & Investment Income: 2023-2025

Historic Interest & Investment Income for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $4.1 million.

  • Upstream Bio's Interest & Investment Income rose 41.36% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 114.28%. This contributed to the annual value of $12.1 million for FY2024, which is 191.07% up from last year.
  • As of Q3 2025, Upstream Bio's Interest & Investment Income stood at $4.1 million, which was down 7.36% from $4.4 million recorded in Q2 2025.
  • Upstream Bio's Interest & Investment Income's 5-year high stood at $5.1 million during Q4 2024, with a 5-year trough of $1.3 million in Q1 2024.
  • In the last 3 years, Upstream Bio's Interest & Investment Income had a median value of $2.9 million in 2024 and averaged $3.2 million.
  • Data for Upstream Bio's Interest & Investment Income shows a peak YoY surged of 274.64% (in 2025) over the last 5 years.
  • Over the past 3 years, Upstream Bio's Interest & Investment Income (Quarterly) stood at $1.5 million in 2023, then soared by 234.17% to $5.1 million in 2024, then surged by 41.36% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $4.4 million for Q2 2025, and $4.7 million during Q1 2025.